In previously published, independent cohorts of localized hormone-sensitive PCa, meta-analysis identified a consistent association with ZFP36/TTP loss and increased risk of biochemical recurrence and development of lethal disease after curative therapy (Figure 1A, left) (14, 15). The gene discussed is ZFP36; the disease is posterior cortical atrophy.